Status:
COMPLETED
An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Growth Hormone Disorder
Adult Growth Hormone Deficiency
Eligibility:
All Genders
18+ years
Brief Summary
This observational study is conducted in Europe. The aim of this observational study is to investigate the changes in a score (GET-score) which includes quality of life, body composition and cholester...
Eligibility Criteria
Inclusion
- Severe acquired growth hormone deficiency
- No treatment with somatropin in the last 24 months before study participation
- Written informed consent
Exclusion
- Contraindications for the treatment with somatropin
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT00934063
Start Date
July 1 2009
End Date
June 1 2014
Last Update
April 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mainz, Germany, 55127